Diffuse panbronchiolitis

Clin Chest Med. 2012 Jun;33(2):297-305. doi: 10.1016/j.ccm.2012.02.005. Epub 2012 Mar 31.

Abstract

Diffuse panbronchiolitis (DPB) is characterized by chronic airway infection with diffuse bilateral micronodular pulmonary lesions. DPB is mainly distributed in east Asian people. Studies on causes of the disease point to a genetic predisposition unique to Asians. The advent of low-dose, long-term macrolide therapy has changed disease prognosis. The mechanism of action is attributed to anti-inflammatory actions of 14-membered and 15-membered ring macrolides. Recently, the success of macrolide therapy in DPB has extended its application to the treatment of other chronic airway inflammatory diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Asia, Eastern / epidemiology
  • Bronchiolitis* / diagnosis
  • Bronchiolitis* / epidemiology
  • Bronchiolitis* / etiology
  • Bronchiolitis* / therapy
  • Haemophilus Infections* / diagnosis
  • Haemophilus Infections* / epidemiology
  • Haemophilus Infections* / etiology
  • Haemophilus Infections* / therapy
  • Humans
  • Macrolides / therapeutic use
  • Practice Guidelines as Topic
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents
  • Macrolides

Supplementary concepts

  • Diffuse panbronchiolitis